Form 8-K - Current report:
SEC Accession No. 0001104659-24-119717
Filing Date
2024-11-15
Accepted
2024-11-15 16:13:33
Documents
14
Period of Report
2024-11-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428216d1_8k.htm   iXBRL 8-K 28472
  Complete submission text file 0001104659-24-119717.txt   251440

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA abt-20241112.xsd EX-101.SCH 3369
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abt-20241112_def.xml EX-101.DEF 28284
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE abt-20241112_lab.xml EX-101.LAB 37481
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abt-20241112_pre.xml EX-101.PRE 26508
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2428216d1_8k_htm.xml XML 5628
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

EIN.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 241468019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)